226
Views
14
CrossRef citations to date
0
Altmetric
Infectious Diseases

How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives

&
Pages 498-504 | Received 30 Dec 2015, Accepted 27 Feb 2016, Published online: 04 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shari R. Lipner. (2019) Pharmacotherapy for onychomycosis: new and emerging treatments. Expert Opinion on Pharmacotherapy 20:6, pages 725-735.
Read now
Aditya K. Gupta, Tracey C. Vlahovic, Kelly A. Foley, Nicole Gellings Lowe, Rob Turner, Marc Brown & Steve Hall. (2018) In vitro efficacy of tavaborole topical solution, 5% after penetration through nail polish on ex vivo human fingernails. Journal of Dermatological Treatment 29:6, pages 633-636.
Read now

Articles from other publishers (12)

Batheesh Ramzy, Avitan‐Hersh Emily, Badi Jiryis & Khamaysi Ziad. (2023) Nd: YAG 1064 nm laser treatment for onychomycosis ‐ is it really effective? A prospective assessment for efficiency and factors contributing to response . Mycoses 67:1.
Crossref
Liubov Kotrekhova, Ekaterina Nikolaevna Tsurupa, Galina Chilina, Ilia Bosak & Arina Vashkevich. (2023) Justified use of 5 % amorolfine nail lacquer, in the treatment of toe onychomycosis. Vestnik dermatologii i venerologii.
Crossref
Pollyanna Cristina Vincenzi Conrado, Ana Adelia Vaine, Glaucia Sayuri Arita, Karina Mayumi Sakita, Renato Sonchini Gonçalves, Wilker Caetano, Monique de Souza, Mauro Luciano Baesso, Luis Carlos Malacarne, Emanuel Razzolini, Vânia Aparecida Vicente, Erika Seki Kioshima & Patrícia de Souza Bonfim de Mendonça. (2023) Promising onychomycosis treatment with hypericin-mediated photodynamic therapy: Case reports. Photodiagnosis and Photodynamic Therapy 42, pages 103498.
Crossref
Julianne M. Falotico, Amar D. Desai & Shari R. Lipner. (2023) Funding is associated with increased methodological and statistical reporting in onychomycosis randomised controlled/comparative clinical trials. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-3.
Crossref
Ulrike Blume‐Peytavi, Antonella Tosti, Meritxell Falqués, Maria Luisa Tamarit, Cristina Carreño, Jordi Galván & Veronica Tebbs. (2021) A multicentre, randomised, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis. Mycoses.
Crossref
Jae Wan Park, Young Gue Koh, Seong Jun Seo & Kui Young Park. (2021) Photodynamic Therapy Combined with 1064-nm Nd:YAG Laser Therapy and Topical Efinaconazole for Refractory Onychomycosis: Case Series. Medical Lasers 10:3, pages 185-188.
Crossref
Jaroslav Lux, Radim Dobiáš, Ivana Kuklová, Radek Litvik, Vladimír Scholtz, Hana Soušková, Josef Khun, Jakub Mrázek, Michaela Kantorová, Pavla Jaworská, Táňa Prejdová, Jana Šnupárková, Petr Hamal & Jaroslav Julák. (2020) Inactivation of Dermatophytes Causing Onychomycosis and Its Therapy Using Non-Thermal Plasma. Journal of Fungi 6:4, pages 214.
Crossref
Shari R. Lipner & Richard K. Scher. (2019) Onychomycosis. Journal of the American Academy of Dermatology 80:4, pages 853-867.
Crossref
A.K. Gupta, S.G. Versteeg & N.H. Shear. (2019) A practical application of onychomycosis cure - combining patient, physician and regulatory body perspectives. Journal of the European Academy of Dermatology and Venereology 33:2, pages 281-287.
Crossref
Yang Won Lee. (2019) Treatment of onychomycosis. Journal of the Korean Medical Association 62:7, pages 385.
Crossref
Aditya K. Gupta, Sarah G. Versteeg & Neil H. Shear. (2017) Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. Journal of Cutaneous Medicine and Surgery 21:6, pages 525-539.
Crossref
A.K. Gupta & S.G. Versteeg. (2017) A critical review of improvement rates for laser therapy used to treat toenail onychomycosis. Journal of the European Academy of Dermatology and Venereology 31:7, pages 1111-1118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.